D.J. Plevak et al conducted a study on liver transplant patients to show blood/donor conservation and cost per test using the TEG® coagulation analyzer  rather than commonly-used coagulation tests (CCT). 

The TEG® system was designed to be specific in determining whether the developing clot can sustain hemostasis. If it can, then the use of commonly-used coagulation tests adds unnecessary cost.